Bosulif 100 MG tablet 120S
Ended Awarded
- Contract number
- SPE2DB25FKD41
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $34,119
Award facts
- Contract value 100% obligated
- $34,119.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on September 28, 2025, for the supply of BOSULIF 100 MG tablets (120-count units) with a ceiling value of $34,119.20. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of October 20, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which is valued at $999,999,999.00 and extends through December 2026, serving as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, is a critical federal medical procurement vendor for military and veteran healthcare systems. The company's portfolio with the DLA encompasses a broad range of pharmaceutical products and medical supplies across multiple therapeutic domains. The company was competitively selected for this award, demonstrating its capability to meet federal procurement requirements. BOSULIF (bosutinib) is an oral tyrosine kinase inhibitor used in the treatment of chronic myeloid leukemia, reflecting the specialized oncology medications within AmerisourceBergen's federal supply network supporting Defense Health Agency and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FKD41?
SPE2DB25FKD41 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 28, 2025.
How much is contract SPE2DB25FKD41 worth?
The government has obligated $34,119 on SPE2DB25FKD41.
Is contract SPE2DB25FKD41 an order under another contract?
Yes. SPE2DB25FKD41 is a delivery order under SPE2DB22D2206, an indefinite delivery contract.
Was contract SPE2DB25FKD41 competed?
The extent of competition for SPE2DB25FKD41 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award